Skip to content
Screener

Nurix Therapeutics, Inc. NRIX Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Arvinas logo
ArvinasARVN
$1.8M-5.3%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$12.12M+3.0%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$4.63M+13.1%
Septerna, Inc. logo
Septerna, Inc.SEPN
$2.41M+18.9%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$2.43M+3.5%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$3.14M-21.1%

Other financials

Income statement

See full
Revenue$9.0M-79.5%
Operating income-$94.2M-95.0%
Net income-$89.5M-106%
EPS (diluted)-$0.81-55.8%

Balance sheet

See full
Cash & equivalents$68.7M-19.4%
Total debt$58.1M+12.0%
Total equity$402.6M-10.0%
Total assets$535.5M-9.5%

Cash flow

See full
Operating cash flow-$96.6M-52.9%
CapEx$1.9M-27.6%
Free cash flow-$98.5M-49.6%

Valuation

See full
Market cap$2.65B+259%
Enterprise value$2.64B+275%
P/S72.1×+63.7×

Profitability

See full
Operating margin-982.4%-1,538pp
Net margin-928.4%-1,403pp
FCF margin-378.7%+24.1pp

Returns & leverage

See full
Return on equity-80.3%+113pp
Debt / equity0.1×0.0×
Current ratio6.3×-0.5×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.

Filed
Jul 9, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001549595-26-000040
Line itemMay 31,2026November 30,2025
Current liabilities:
Accounts payable$12,208$11,215
Accrued expenses and other current liabilities43,26754,852
Operating lease liabilities, current3,2212,824
Deferred revenue, current13,32417,580
Total current liabilities72,02086,471
Operating lease liabilities, net of current portion54,92252,906
Deferred revenue, net of current portion5,97110,011

Item 1. Financial Statements (Unaudited)

FAQ

What is Nurix Therapeutics, Inc.'s operating lease liabilities (current)?
Nurix Therapeutics, Inc. (NRIX) reported operating lease liabilities (current) of $3.22M in Q1 2026.
How has Nurix Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
Nurix Therapeutics, Inc.'s operating lease liabilities (current) decreased by 38.5% year-over-year, from $5.24M to $3.22M.
What is the long-term trend for Nurix Therapeutics, Inc.'s operating lease liabilities (current)?
Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s operating lease liabilities (current) has grown at a -3.3% compound annual growth rate (CAGR), from $3.34M to $2.82M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Nurix Therapeutics, Inc.'s operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude